RecruitingNot ApplicableNCT06945484

PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Sponsor

University of Utah

Enrollment

20 participants

Start Date

Nov 21, 2025

Study Type

INTERVENTIONAL

Conditions

NSCLC Stage II

Summary

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is testing a personalized exercise program — called PERCC (Precision Exercise Regimen for Cancer Care) — for people with stage II or III non-small cell lung cancer who are undergoing chemotherapy or immunotherapy followed by surgery. The goal is to see if structured exercise improves recovery. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with stage II or III non-small cell lung cancer (NSCLC) - You are receiving neoadjuvant (pre-surgery) chemotherapy or immunotherapy, followed by surgery - You can understand and follow directions and complete questionnaires in English or Spanish - You agree to participate in the exercise program **You may NOT be eligible if...** - Your BMI is above 40 (morbid obesity) or below 17.5 (severely underweight) - You have physical conditions that would make an exercise program unsafe - You have significant alcohol use or other health issues that would prevent safe participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPrecision Exercise Regimen for Cancer Care (PERCC)

PERCC has exercise modes including basic transfer and calisthenics mobility, aerobic, and resistance exercises, and will be performed in various postures (supine, sitting, standing, and walking) with variable challenges (level walking, bending, inclines, steps, and squatting). Each participant will complete one supervised, home-based exercise training session per week, delivered through telehealth, that will focus on the resistance exercise prescription. Other unsupervised exercise training sessions will focus on the aerobic exercise prescription and will be completed individually

Locations(2)

University of Texas Medical Branch at Galveston

Galveston, Texas, United States

Huntsman Cancer Institute

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06945484

Related Trials

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

NCT073237327 locations

Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer

NCT074109751 location

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

NCT048652501 location

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

NCT042055524 locations